Business multiple sclerosis

Multiple sclerosis drug to be studied for COVID-19 treatment

Large, ongoing studies of remdesivir are set to enter a new phase of research, in which doctors will test the impact of combining the drug with a medication already approved to treat multiple sclerosis, the National Institutes of Health announced Wednesday.The multiple sclerosis drug, called interferon beta-1a, is sold under the brand name Rebif. It’s…